Figure 2.
JAK inhibitor (ligand) and JAK complex. (a) Tofacitinib/PDB:3EYG(JAK1/2); (b) PF–06700841/PDB:6DBN(JAK1); (c) 3C9/PDB:4QT1(JAK3). Hydrogen bonds were shown as red lines.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.